Abstract
Forty six normal volunteers were randomly assigned in double-blind fashion to once daily orally administered nadolol 10, 20, 40, or 80 mg for five days. Significant and dose related intraocular pressure (IOP) reductions (range 20-40%) were demonstrated both at three hours and 24 hours post dosing (p less than 0.001, all dosages). The reductions in IOP were dose related (p less than 0.05). One subject (in the 10 mg group) failed to show a significant intraocular pressure reduction. Significant reductions in blood pressure and heart rate also were recorded at all dose levels (with the exception of diastolic pressure in the 10 mg group), though considerably less in degree than IOP reductions. Two subjects (20 mg and 80 mg groups) experienced known side effects of beta blocker therapy necessitating termination of the drug, and four others experienced mild side effects but had no difficulty completing the study. The results have prompted further investigation of the usefulness of low doses of oral nadolol as therapy in chronic simple glaucoma patients.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Boger W. P., 3rd, Puliafito C. A., Steinert R. F., Langston D. P. Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma. Ophthalmology. 1978 Mar;85(3):259–267. doi: 10.1016/s0161-6420(78)35673-6. [DOI] [PubMed] [Google Scholar]
- Brenkman R. F. Long-term hypotensive effect of atenolol 4% eyedrops. Br J Ophthalmol. 1978 May;62(5):287–291. doi: 10.1136/bjo.62.5.287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frishman W. Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: a new long-acting beta-adrenoceptor blocking drug. Am Heart J. 1980 Jan;99(1):124–128. doi: 10.1016/0002-8703(80)90322-1. [DOI] [PubMed] [Google Scholar]
- Ohrström A., Pandolfi M. Regulation of intraocular pressure and pupil size by beta-blockers and epinephrine. Arch Ophthalmol. 1980 Dec;98(12):2182–2184. doi: 10.1001/archopht.1980.01020041034005. [DOI] [PubMed] [Google Scholar]
- Phillips C. I., Howitt G., Rowlands D. J. Propranolol as ocular hypotensive agent. Br J Ophthalmol. 1967 Apr;51(4):222–226. doi: 10.1136/bjo.51.4.222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thomas J. V., Epstein D. L. Timolol and epinephrine in primary open angle glaucoma. Transient additive effect. Arch Ophthalmol. 1981 Jan;99(1):91–95. doi: 10.1001/archopht.1981.03930010093010. [DOI] [PubMed] [Google Scholar]
- Wettrell K., Pandolfi M. Effect of oral administration of various beta-blocking agents on the intraocular pressure in healthy volunteers. Exp Eye Res. 1975 Nov;21(5):451–456. doi: 10.1016/0014-4835(75)90126-8. [DOI] [PubMed] [Google Scholar]